BioSpace News Archive

Progenity, Inc., an innovative biotechnology company, announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock and warrants to purchase shares of its common stock in an underwritten public offering.

Marker Therapeutics, Inc. (Nasdaq:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced that the Company received notice of a Product Development Research award totaling approximately $13.1 million.

Kadmon Holdings, Inc. announced that REZUROCK™ 200 mg once daily tablets is now commercially available for shipment to prescribed patients in the United States.

Cerner Corporation (Nasdaq: CERN) today announced that its Board of Directors has appointed David Feinberg, M.D., MBA, as President and Chief Executive Officer, effective October 1, 2021.

Bristol Myers Squibb Receives European Commission Approval for Abecma (Idecabtagene Vicleucel), the First Anti-BCMA CAR T Cell Therapy for Relapsed and Refractory Multiple Myeloma

Neurophth Biotechnology Ltd. today announced the recent appointment of Dr. Zhengbin ( Luke) Li as the Head of Commercial.

This software will significantly improve ease of use and enable both beginners and experts to get better data, faster. With a fresh new look, Aura 4.0 is a major release with significant new features and product enhancements.

Brain metastasis is a type of cancer caused when cancer cells spread from their original site to the brain.

Hydrophobic Introduction Chromatography is a technology for separating compounds based on their hydrophobicity properties.

Prostate cancer is diagnosed when cells in the prostate gland start to grow abnormally and uncontrollably.